ML-385 | Interleukin Related interleukin-related.com

Product Name :
ML-385

Search keywords :
ML385

drugId :
null

Target Vo:
Nuclear factor erythroid 2-related factor 2

Target Vo Short Name :
Nrf2

Moa_Name:
Nuclear factor erythroid 2-related factor 2 stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johns Hopkins University

Active Company_Name :
Johns Hopkins University

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
STAT1 Antibody (YA059)
Phospho-p38 (Thr180/Tyr182) Antibody
MMAF Antibody (YA900): MMAF Antibody (YA900) is an unconjugated, mouse-derived, anti-MMAF (YA900) monoclonal antibody. MMAF Antibody (YA900) can be used for: ELISA, Sandwich ELISA, Competitive ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts